    Wingate, Russotti & Shapiro wins $1,350,000.00 verdict $8.5 Million Verdict $4.5 million recovery $1,400,000 Million Settlement $3,900,000 Recovery Wingate, Russotti & Shapiro wins |
New York Vioxx Side Effects LawyersIf you or a loved one has taken the prescription drug Vioxx, you should seek medical attention right away and discontinue use of the drug. If you have experienced any of the serious side effects associated with Vioxx, such as a stroke or heart attack you should hire a Vioxx lawyer from Wingate, Russotti & Shapiro to represent your case. Our New York personal injury firm was established in 1990, and has recovered millions of dollars for our seriously injured clients throughout New York. We are dedicated to protecting the rights of our injured clients and have the legal expertise to represent even the most challenging cases. Call Wingate, Russotti & Shapiro today to discuss your Vioxx case with one of our experienced Vioxx lawyers. VIOXX IN THE NEWSJournal Runs Correction on Vioxx By Denise Gellene, Times Staff Writer The withdrawn painkiller Vioxx could cause heart problems for patients taking it for less than 18 months, according to a correction in the New England Journal of Medicine that disputes the company's contention that the drug was safe when taken for a short time. The journal said the original statistical analysis of a March 2005 study was incorrect and it was uncertain how long the drug could be safely taken before patients incurred an increased risk of stroke and heart attack. Click here to read the entire story. Click here to read the report by the New England Journal of Medicine. Cardiologist says Vioxx still a risk after stopping By Bill Berkrot NEW YORK (Reuters) - A leading cardiologist on Friday disputed Merck & Co's interpretation on the safety of patients once they stop taking Vioxx, saying they remained at high risk of heart attacks or strokes for some time afterward. Dr Steven Nissen, interim chairman of cardiology at the prestigious Cleveland Clinic, said Merck misrepresented an analysis of data from a follow-up review of patients involved in the trial that led to the pain medication being pulled from the market. Click here to read the entire story. FDA Public Health Advisory - Non-Steroidal Anti-Inflammatory
Drug Products (NSAIDS) The FDA is issuing a public health advisory concerning use of non-steroidal anti-inflammatory drug products (NSAIDS) including those known as COX-2 selective agents. Recently released data from controlled clinical trials showing that the COX-2 selective agents (Vioxx, Celebrex, and Bextra) may be associated with an increased risk of serious cardiovascular events (heart attack and stroke) especially when they are used for long periods of time or in very high risk settings (immediately after heart surgery). Click here to read the entire advisory. FDA Issues Public Health Advisory Recommending Limited
Use of Cox-2 Inhibitors - Agency Requires Evaluation of Prevention Studies
Involving Cox-2 Selective Agents The Food and Drug Administration (FDA) today issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents. The public health advisory is an interim measure, pending further review of data that continue to be collected. In addition, FDA today announced that it is requiring evaluation of all prevention studies that involve the Cox-2 selective agents Celebrex (celecoxib) and Bextra (valdecoxib) to ensure that adequate precautions are implemented in the studies and that local Institutional Review Boards reevaluate them in light of the new evidence that these drugs may increase the risk of heart attack and stroke. A prevention trial is one in which healthy people are given medicine to prevent a disease or condition (such as colon polyps or Alzheimer's disease). Click here to read the entire paper. Statement of Sandra Kweder, M.D., Deputy Director, Office
of New Drugs at the Center for Drug Evaluation and Research, FDA Modern drugs provide unmistakable and significant health benefits. It is well recognized that FDA's drug review is a gold standard. Indeed, we believe that FDA maintains the highest worldwide standards for drug approval. FDA grants approval to drugs after a sponsor demonstrates that they are safe and effective. Experience has shown that the full magnitude of some potential risks do not always emerge during the mandatory clinical trials conducted before approval to evaluate these products for safety and effectiveness. Occasionally, serious adverse effects are identified after approval either in post-marketing clinical trials or through spontaneous reporting of adverse events. That is why Congress has supported and FDA has created a strong post-market drug safety program designed to assess adverse events identified after approval for all of the medical products it regulates as a complement to the pre-market safety reviews required for approval of prescription drugs in the United States. Monitoring the drug safety of marketed products requires close collaboration between our clinical reviewers and drug safety staff to evaluate and respond to adverse events identified in ongoing clinical trials or reported to us by physicians and their patients. The most recent actions concerning the drug Vioxx (rofecoxib) illustrates the vital importance of the ongoing assessment of the safety of a product once it is in widespread use. Click here to read the entire statement. Merck Revises Number of Vioxx Prescriptions WHITEHOUSE STATION, N.J. - (Dow Jones) - Merck & Co. (NYSE:MRK) (MRK) clarified the number of patients and prescriptions in the U.S. for its arthritis pain drug Vioxx in response to inaccuracies reported on Thursday. Click here to read the entire story. Pulling arthritis drug Vioxx increases on Merck & Co. NEW YORK (AP) - The stunning news that Merck & Co. is withdrawing its pain reliever Vioxx from the market because of health risks is the latest in a series of blows to what only a few years ago was the world's largest drugmaker and the envy of the industry for its research and development prowess. Click here to read the entire story. Merck halts Vioxx sales The maker of blockbuster pain reliever Vioxx said Thursday that it is voluntarily withdrawing the drug because of new data showing it increases the risk of heart attacks and strokes. This is one of the largest - ever withdrawals of a drug, says the Food and Drug Administration's Steven Galson. Click here to read the entire story. Merck Pulls Arthritis Drug Vioxx from Market Pharmaceutical giant Merck & Co. is pulling its arthritis drug Vioxx from the market after a study confirmed earlier concerns that it raises the risk of heart problems, including heart attacks and stroke. Vioxx is currently used by 2 million people worldwide and has been used by more than 84 million people around the world, according to Merck. Click here to read the entire story. Coping Without Vioxx Merck & Co.'s abrupt decision to pull the blockbuster drug Vioxx from the market will force millions of patients to find alternative options to alleviate pain from arthritis and other maladies. There are plenty of other treatments available, but figuring out which ones are right for which patients will depend on a variety of factors -- most notably heart-disease risk and history of ulcers. Click here to read the entire story If you or a loved one has taken Vioxx and suffered any of the serious side effects associated with the drug, call Wingate, Russotti & Shapiro today for a free consultation with an experienced New York Vioxx Attorney. |
An attorney client relationship is not established by submitting this initial contact information.
420 Lexington Avenue
Suite 2750 New York, NY 10170 Telephone: 212-986-7353 Fax: 212-953-4308 E-mail: wrs@wrslaw.com |
New York Vioxx Side Effects Lawyer Disclaimer: The New York Vioxx, Vioxx side effects, Vioxx in the news, stroke, or other legal information presented at this site should not be construed to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Any results set forth herein are based upon the facts of that particular case and do not represent a promise or guarantee. Please contact a New York Vioxx Side Effects Lawyer or Vioxx Attorney for a consultation on your particular personal injury matter. This web site is not intended to solicit clients for matters outside of the state of New York.
© 2008 Wingate, Russotti & Shapiro, LLP – All rights reserved. New York Vioxx Side Effects Attorneys – Vioxx Injury Lawyers serving the communities of New York City, Manhattan, Queens, Staten Island, Bronx, Brooklyn, Long Island, Westchester County, Rockland County, Nassau County, Suffolk County and all upstate New York Counties.
Attorney Advertising
Sitemap
Internet Marketing: SLS
Consulting